Actuate Therapeutics, Inc. Common stock ACTU
0.35 USD 0.00 (+0.77%)
Nov 4, 2026, 1:09 PM EST
0.341 Day range 0.3698
0.33 52-week range 7.90
- YTD
- -94.24%
- 1 year
- -94.51%
Financial health
Altman Z-Score
-56.02 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 1
Valuation
P/E -5.8×
FY 2022 5y median -5.5× FY 2025
P/S 0.0×
FY 2022 5y median 0.0× FY 2025
P/B 16.2×
FY 2022 5y median 12.5× FY 2025
P/FCF -6.7×
FY 2022 5y median -6.9× FY 2025
EV/EBITDA -5.2×
FY 2022 5y median 229× FY 2025
EV/Sales 0.0×
FY 2022 5y median 0.0× FY 2025
FCF Yield -14.9%
FY 2022 5y median -14.5% FY 2025
Profitability
Gross Margin 0.0%
FY 2022 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2022 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2022 5y median 0.0% FY 2025
ROE -280.5%
FY 2022 5y median -208.2% FY 2025
ROIC -270.1%
FY 2022 5y median -197.6% FY 2025
ROA -158.4%
FY 2022 5y median -225.6% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2022 FY 2025
Operating Income 10.6%
FY 2022 FY 2025
EPS (diluted) 67.5%
FY 2022 FY 2025
Free Cash Flow 12.1%
FY 2022 FY 2025
Financial Health
Current Ratio 2.4×
FY 2022 5y median 1.7× FY 2025
Quick Ratio 2.4×
FY 2022 5y median 1.7× FY 2025
Debt / Equity 0.1×
FY 2022 5y median 0.0× FY 2025
Net Debt / EBITDA 0.6×
FY 2022 5y median -5.1× FY 2025
Interest Coverage -1111×
FY 2022 5y median -842× FY 2025
Dividends
Dividend Yield 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31